1
|
Living donor liver transplantation: the Asian perspective.
|
Transplantation
|
2014
|
2.13
|
2
|
Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis.
|
Liver Transpl
|
2007
|
2.09
|
3
|
Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation?
|
Surgery
|
2010
|
1.82
|
4
|
Auxiliary partial orthotopic living donor liver transplantation: Kyoto University experience.
|
Am J Transplant
|
2005
|
1.70
|
5
|
Left-sided grafts for living-donor liver transplantation and split grafts for deceased-donor liver transplantation: their impact on long-term survival.
|
Clin Res Hepatol Gastroenterol
|
2011
|
1.63
|
6
|
Comprehensive and innovative techniques for liver transplantation in rats: a surgical guide.
|
World J Gastroenterol
|
2010
|
1.57
|
7
|
Pre- and perioperative factors affecting infection after living donor liver transplantation.
|
Nutrition
|
2012
|
1.46
|
8
|
Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications.
|
Transplantation
|
2003
|
1.45
|
9
|
Living-donor liver transplantation with monosegments.
|
Transplantation
|
2003
|
1.45
|
10
|
Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation.
|
Liver Transpl
|
2007
|
1.27
|
11
|
CTRP9 protein protects against myocardial injury following ischemia-reperfusion through AMP-activated protein kinase (AMPK)-dependent mechanism.
|
J Biol Chem
|
2012
|
1.26
|
12
|
Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients.
|
Clin Pharmacol Ther
|
2006
|
1.20
|
13
|
Small-for-size graft in living donor liver transplantation: how far should we go?
|
Liver Transpl
|
2003
|
1.19
|
14
|
IFN-gamma, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses.
|
Am J Transplant
|
2005
|
1.14
|
15
|
Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria.
|
Dig Dis
|
2007
|
1.11
|
16
|
Posttransplant bacteremia in adult living donor liver transplant recipients.
|
Liver Transpl
|
2010
|
1.10
|
17
|
Surgery-related morbidity in living donors of right-lobe liver graft: lessons from the first 200 cases.
|
Transplantation
|
2003
|
1.09
|
18
|
Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
|
Pharmacogenet Genomics
|
2008
|
1.08
|
19
|
"Small-for-size graft" and "small-for-size syndrome" in living donor liver transplantation.
|
Yonsei Med J
|
2004
|
1.05
|
20
|
Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
|
Clin Cancer Res
|
2005
|
1.03
|
21
|
Impact of right lobe with middle hepatic vein graft in living-donor liver transplantation.
|
Am J Transplant
|
2005
|
1.02
|
22
|
Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation.
|
FASEB J
|
2012
|
1.02
|
23
|
Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab.
|
Transplantation
|
2012
|
1.01
|
24
|
Surgery-related morbidity in living donors for liver transplantation.
|
Transplantation
|
2010
|
0.96
|
25
|
Overexpression of c-met in the early stage of pancreatic carcinogenesis; altered expression is not sufficient for progression from chronic pancreatitis to pancreatic cancer.
|
World J Gastroenterol
|
2006
|
0.95
|
26
|
CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantation.
|
Pharmacogenetics
|
2004
|
0.94
|
27
|
End-to-side portocaval shunting for a small-for-size graft in living donor liver transplantation.
|
Liver Transpl
|
2004
|
0.93
|
28
|
Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients.
|
Clin Pharmacol Ther
|
2006
|
0.92
|
29
|
Efficacy and safety of prophylaxis with entecavir and hepatitis B immunoglobulin in preventing hepatitis B recurrence after living-donor liver transplantation.
|
Hepatol Res
|
2012
|
0.92
|
30
|
Impact of intestinal CYP2C19 genotypes on the interaction between tacrolimus and omeprazole, but not lansoprazole, in adult living-donor liver transplant patients.
|
Drug Metab Dispos
|
2009
|
0.92
|
31
|
Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
|
Clin Pharmacol Ther
|
2005
|
0.92
|
32
|
Hepatic venous outflow obstruction in pediatric living donor liver transplantation using left-sided lobe grafts: Kyoto University experience.
|
Liver Transpl
|
2010
|
0.91
|
33
|
Living-related liver transplantation for Alagille syndrome.
|
Transplantation
|
2003
|
0.88
|
34
|
Appleby operation for pancreatic body-tail carcinoma: report of three cases.
|
Surg Today
|
2003
|
0.87
|
35
|
Long-term outcomes of 600 living donor liver transplants for pediatric patients at a single center.
|
Liver Transpl
|
2006
|
0.87
|
36
|
Cyclosporine exposure and calcineurin phosphatase activity in living-donor liver transplant patients: twice daily vs. once daily dosing.
|
Liver Transpl
|
2006
|
0.86
|
37
|
De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
|
Antivir Ther
|
2011
|
0.86
|
38
|
Progressive familial intrahepatic cholestasis: a single-center experience of living-donor liver transplantation during two decades in Japan.
|
Clin Transplant
|
2010
|
0.85
|
39
|
Successful treatment of pulmonary hypertension secondary to congenital extrahepatic portocaval shunts (Abernethy type 2) by living donor liver transplantation after surgical shunt ligation.
|
Transpl Int
|
2009
|
0.85
|
40
|
The role of apheresis therapy in living donor liver transplantation.
|
Ther Apher Dial
|
2004
|
0.85
|
41
|
Classification of human liver transplant recipients by their preoperative CD8+ T cell subpopulation and its relation to outcome.
|
Liver Transpl
|
2006
|
0.85
|
42
|
Delayed effect of grapefruit juice on pharmacokinetics and pharmacodynamics of tacrolimus in a living-donor liver transplant recipient.
|
Drug Metab Pharmacokinet
|
2006
|
0.84
|
43
|
NK cells and transplantation.
|
Transpl Immunol
|
2002
|
0.84
|
44
|
A case of inflammatory pseudotumor of the liver hilum successfully treated with aggressive hepatectomy.
|
J Pediatr Surg
|
2003
|
0.84
|
45
|
Effects of post-transplant enteral nutrition with an immunomodulating diet containing hydrolyzed whey peptide after liver transplantation.
|
World J Surg
|
2012
|
0.83
|
46
|
Identification, cloning, and characterization of a novel rat natural killer receptor, RNKP30: a molecule expressed in liver allografts.
|
Transplantation
|
2004
|
0.83
|
47
|
A case of adult-to-adult living donor liver transplantation using right and left lateral lobe grafts from 2 donors.
|
Surgery
|
2002
|
0.83
|
48
|
Frequent incidence of escape mutants after successful hepatitis B vaccine response and stopping of nucleos(t)ide analogues in liver transplant recipients.
|
Liver Transpl
|
2014
|
0.83
|
49
|
Impact of pretransplant nutritional status in patients undergoing liver transplantation.
|
Hepatogastroenterology
|
2011
|
0.83
|
50
|
Living-donor liver transplantation for situs inversus: 2 case reports.
|
J Pediatr Surg
|
2005
|
0.83
|
51
|
Successful liver transplantation for congenital absence of the portal vein complicated by intrapulmonary shunt and brain abscess.
|
J Pediatr Surg
|
2005
|
0.82
|
52
|
How transplant surgeons can overcome the inevitable insufficiency of allograft size during adult living-donor liver transplantation: strategy for donor safety with a smaller-size graft and excellent recipient results.
|
Clin Transplant
|
2012
|
0.82
|
53
|
Total pancreatectomy for intraductal papillary-mucinous tumor of the pancreas: reappraisal of total pancreatectomy.
|
Hepatogastroenterology
|
2005
|
0.82
|
54
|
Impact of glutathione S-transferase T1 gene polymorphisms on acute cellular rejection in living donor liver transplantation.
|
Transpl Immunol
|
2012
|
0.82
|
55
|
MDR1 haplotypes conferring an increased expression of intestinal CYP3A4 rather than MDR1 in female living-donor liver transplant patients.
|
Pharm Res
|
2009
|
0.82
|
56
|
Non-inflammatory centrilobular sinusoidal fibrosis in pediatric liver transplant recipients under tacrolimus withdrawal.
|
Hepatol Res
|
2012
|
0.81
|
57
|
Long-term outcomes for 32 cases of Wilson's disease after living-donor liver transplantation.
|
Transplantation
|
2009
|
0.81
|
58
|
Functional portal flow competition after auxiliary partial orthotopic living donor liver transplantation in noncirrhotic metabolic liver disease.
|
J Pediatr Surg
|
2004
|
0.81
|
59
|
Variations in biliary anatomy associated with trifurcated portal vein in right-lobe living-donor liver transplantation.
|
Transplantation
|
2005
|
0.81
|
60
|
Apheresis therapy for living-donor liver transplantation: experience for apheresis use for living-donor liver transplantation at Kyoto University.
|
Ther Apher
|
2002
|
0.81
|
61
|
Impact of enteral nutrition using a new immuno-modulating diet after liver transplantation.
|
Hepatogastroenterology
|
2011
|
0.81
|
62
|
Pediatric orthotopic living-donor liver transplantation cures pulmonary hypertension caused by Abernethy malformation type Ib.
|
Pediatr Transplant
|
2011
|
0.80
|
63
|
Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan.
|
World J Gastroenterol
|
2011
|
0.80
|
64
|
Standard hepatic vein reconstruction with patch plasty using the native portal vein in adult living donor liver transplantation.
|
Liver Transpl
|
2012
|
0.80
|
65
|
Absence of influence of concomitant administration of rabeprazole on the pharmacokinetics of tacrolimus in adult living-donor liver transplant patients: a case-control study.
|
Drug Metab Pharmacokinet
|
2009
|
0.79
|
66
|
Living donor liver transplantation for recurrent hepatocellular carcinoma after liver resection.
|
Surgery
|
2011
|
0.79
|
67
|
Interaction between tacrolimus and lansoprazole, but not rabeprazole in living-donor liver transplant patients with defects of CYP2C19 and CYP3A5.
|
Drug Metab Pharmacokinet
|
2008
|
0.79
|
68
|
Can children catch up in growth after living donor liver transplantation?
|
Liver Transpl
|
2010
|
0.79
|
69
|
Significance of trough monitoring for tacrolimus blood concentration and calcineurin activity in adult patients undergoing primary living-donor liver transplantation.
|
Eur J Clin Pharmacol
|
2011
|
0.78
|
70
|
How do transplant surgeons accomplish optimal portal venous flow during living-donor liver transplantation? Noninvasive measurement of indocyanine green elimination rate.
|
Surg Innov
|
2013
|
0.78
|
71
|
Mesorenal shunt using inferior mesenteric vein and left renal vein in a case of LDLT.
|
Transpl Int
|
2009
|
0.77
|
72
|
Fatal impact of lymphocyte cross-matching upon humoral rejection after adult living related liver transplantation.
|
Transpl Int
|
2009
|
0.77
|
73
|
Impact of preexisting circulating effector T cells on the outcome of ABO-incompatible adult LDLT.
|
Dig Dis Sci
|
2008
|
0.77
|
74
|
Graft reconditioning with nitric oxide gas in rat liver transplantation from cardiac death donors.
|
Transplantation
|
2014
|
0.77
|
75
|
Pediatric living-donor liver transplantation for acute liver failure: analysis of 57 cases.
|
Transpl Int
|
2010
|
0.77
|
76
|
Living donor liver transplantation for Budd-Chiari syndrome with hepatic inferior vena cava obstruction after open pericardial procedures.
|
Surg Today
|
2012
|
0.76
|
77
|
Relation between mRNA expression level of multidrug resistance 1/ABCB1 in blood cells and required level of tacrolimus in pediatric living-donor liver transplantation.
|
J Pharmacol Exp Ther
|
2008
|
0.76
|
78
|
Impact of preoperative uncontrollable hepatic hydrothorax and massive ascites in adult liver transplantation.
|
Surg Today
|
2014
|
0.76
|
79
|
Monosegmental living-donor liver transplantation for infantile hepatic hemangioendothelioma.
|
J Pediatr Surg
|
2003
|
0.76
|
80
|
Plasma cell hepatitis induced by the termination of antiviral therapy for recurrent hepatitis C after living donor liver transplantation.
|
Hepatol Res
|
2013
|
0.76
|
81
|
The technical pitfalls of duct-to-duct biliary reconstruction in pediatric living-donor left-lobe liver transplantation: the impact of stent placement.
|
Pediatr Transplant
|
2007
|
0.76
|
82
|
The impact of meticulous management for hepatic artery thrombosis on long-term outcome after pediatric living donor liver transplantation.
|
Clin Transplant
|
2008
|
0.76
|
83
|
Successful surgical ligation under intraoperative portal vein pressure monitoring of a large portosystemic shunt presenting as an intrapulmonary shunt: report of a case.
|
Surg Today
|
2004
|
0.75
|
84
|
Liver transplantation for congenital biliary dilatation: a single-center experience.
|
Dig Surg
|
2010
|
0.75
|
85
|
Pretransplant serum hepatitis C virus RNA levels predict response to antiviral treatment after living donor liver transplantation.
|
PLoS One
|
2013
|
0.75
|
86
|
Section 7. A new therapeutic strategy on portal flow modulation that increases donor safety with good recipient outcomes.
|
Transplantation
|
2014
|
0.75
|
87
|
Toxicokinetics of perfluoroalkyl carboxylic acids with different carbon chain lengths in mice and humans.
|
J Occup Health
|
2014
|
0.75
|
88
|
Successful stent placement for hepatic venous outflow obstruction in pediatric living donor liver transplantation, including a case series review.
|
Pediatr Transplant
|
2008
|
0.75
|
89
|
Role of bcl-2 mRNA in homeostatic proliferation in circulating T-cells in human liver transplant patients after T-cell depletion.
|
J Surg Res
|
2005
|
0.75
|
90
|
Quantitative survival model for short-term survival after adult-to-adult living donor liver transplantation.
|
Liver Transpl
|
2006
|
0.75
|
91
|
Use of recipient's left colic artery for arterial reconstruction during liver transplantation in Alagille syndrome with vasculopathy: a case report.
|
Transplantation
|
2012
|
0.75
|
92
|
Liver transplantation for severe hepatitis in patients with common variable immunodeficiency.
|
Pediatr Transplant
|
2011
|
0.75
|
93
|
Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseases.
|
Intern Med
|
2014
|
0.75
|
94
|
Recurrence of hepatocellular carcinoma after living donor liver transplantation: what is the current optimal approach to prevent recurrence?
|
World J Surg
|
2011
|
0.75
|
95
|
Liver Transplantation for Non-B and Non-C Hepatocellular Carcinoma.
|
Hepatogastroenterology
|
2015
|
0.75
|
96
|
Radiation therapy, bypass operation and celiac plexus block in patients with unresectable locally advanced pancreatic cancer.
|
Hepatogastroenterology
|
2005
|
0.75
|
97
|
Required transient dose escalation of tacrolimus in living-donor liver transplant recipients with high concentrations of a minor metabolite M-II in bile.
|
Drug Metab Pharmacokinet
|
2008
|
0.75
|
98
|
Subcapsular hematoma after right-lobe living-donor liver transplantation.
|
J Hepatobiliary Pancreat Surg
|
2004
|
0.75
|
99
|
Density-independent high moisture content measurement using phase shifts at two microwave frequencies.
|
J Microw Power Electromagn Energy
|
2010
|
0.75
|
100
|
Liver Transplantation in Adults with Acute Liver Failure: A Single Center Experience over A Period of 15 Years.
|
Hepatogastroenterology
|
2015
|
0.75
|
101
|
The rare insertion of b4 with trifurcated portal vein in live donor.
|
Transplantation
|
2010
|
0.75
|
102
|
Role of HLA compatibility in pediatric living-related liver transplantation.
|
Transplantation
|
2002
|
0.75
|